Berman Medical Inc is currently conducting a FDA clinical trial for a new patented topical MRSA (Methicillin-Resistant Staphylococcus Aureus) bactericidal gel - Vancogel®.

This clinical trial is open to anyone 18 years and older that has an open MRSA infected wound not larger then 50 cm2.

In order to qualify for the trial the patient must have an open MRSA infected wound and be available for 3 weeks for treatments. To download or view our patient brochure click here.

To request more information about the trial or to see if you qualify, please click on contact us and complete the form or you can contact Dr. Berman via email by clicking here.